Cor Vasa 2006, 48(4):150-152 | DOI: 10.33678/cor.2006.048

Clinical manifestation of lithium intoxication following contrast medium injection during selective coronary arteriography

Radek Krejčí*, František Toušek
Kardiocentrum, Nemocnice České Budějovice a. s., České Budějovice, Česká republika

Our case report describes a clinical manifestation of chronic lithium intoxication in a female patient undergoing elective coronary arteriography after myocardial infarction. It shows that even a relatively safe examination, which coronary
arteriography is, can lead to a life-threatening state under certain adverse conditions.

Keywords: Coronary arteriography; Contrast media-induced nephrotoxicity; Lithium intoxication

Published: April 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Krejčí R, Toušek F. Clinical manifestation of lithium intoxication following contrast medium injection during selective coronary arteriography. Cor Vasa. 2006;48(4):150-152. doi: 10.33678/cor.2006.048.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Aschermann M a kol. Kardiologie. Praha: Galén, 2004: 367-76.
    2. Krajina A, Hlava A. Angiografie. Hradec Králové: Nucleus, 1999:73-5.
    3. Morcos SK. Prevention of contrast media nephrotoxicity - the story so far. Clin Radiol 2004;59:381-9. Go to original source... Go to PubMed...
    4. Briguori C, Colombo A, Airoldi F, et al. N-Acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity. J Am Coll Cardiol 2004;44:762-5. Go to original source... Go to PubMed...
    5. Raven QL, Wlaton T, Home AM, et al. Role of acetylcysteine in the prevention of contrast-media-induced nephrotoxicity. Am J Health Syst Pharm 2003;60:2232-5. Go to original source... Go to PubMed...
    6. Thompson EJ, King SZ. Acetylcysteine and fenoldopam. Promising new approaches for preventing effect of contrast nephrotoxicity. Crit Care Nurse 2003;23:36-46. Go to original source...
    7. Alonso A, Lau J, Bertrand LJ, et al. Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: A meta-analysis of randomized, controlled trials. Am J Kid Dis 2004;1:1-9. Go to original source...
    8. Martínek V. Poškození ledvin kontrastními látkami. Interv Akut Kardiol 2002;1:37-40.
    9. Knut JB. Nephrotoxicity related to contrast media. Scan J Urol Nephrol 2000;34:317-22. Go to original source... Go to PubMed...
    10. Ševela K, Ševčík P, Kraus R a kol. Akutní intoxikace v intenzivní medicíně. Praha: Grada Publishing a. s., 2002:181-8.
    11. Oakley PW, Whyte IM, Carter GL. Lithium toxicity: an iatrogenic problem in susceptible individuals. Aust N Z J Psychiatry 2002;36:703.
    12. Spinewine A, Schoevaerdts D, Mwenge G, et al. Drug-induced lithium intoxication: a case report. J Am Geriatr Soc 2005;52:794-8. Go to original source... Go to PubMed...
    13. Nagappan R, Parkin WG, Holsworth SR. Acute lithium intoxication. Anaesthes Intens Care 2002;30:90-2. Go to original source... Go to PubMed...
    14. Bailey B, McGuidan M. Comparison of patients hemodialyzed for lithium poisoning and those for whom dialysis was recommended by PCC but not done: what lesson can we learn? Clin Nephrol 2000;54:388-92. Go to PubMed...
    15. Trivedi HS, Moore H, Nasr S, et al. A randomised prospective trial to asses the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 2003;93:C5-6. Go to original source... Go to PubMed...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes